Firm says it is exporting remdesivir

Published May 4, 2020
Gilead Sciences CEO says company is donating its entire existing supply of the drug — 1.5 million vials. — AFP/File
Gilead Sciences CEO says company is donating its entire existing supply of the drug — 1.5 million vials. — AFP/File

WASHINGTON: The head of the maker of remdesivir, an anti-viral shown to reduce recovery times in Covid-19 patients, said on Sunday the company has been exporting the drug and is making it available to patients in the United States through the US government.

Gilead Sciences CEO Daniel O’Day said the company is donating its entire existing supply of the drug — 1.5 million vials, enough to treat 100,000 to 200,000 patients.

“We have been exporting for clinical trials and for compassionate use thousands of treatment courses,” O’Day said on CBS’s “Face the Nation.” “And our collaboration with the government has been such, we have been very transparent with them here in the United States and we have a good relationship on future allocation.”

US regulators on Friday authorised the experimental drug for emergency use against Covid-19 after a major clinical trial showed it shortened the time to recovery in some coronavirus patients by a third.

It is the first medicine to show beneficial results in treating Covid-19 since the new coronavirus emerged in China late last year. O’Day said the US government will determine how the drug is allocated in the United States based on where it is needed most.

“They will begin shipping tens of thousands of treatment courses out early this week and adjust that as the epidemic shifts and evolves in different parts and different cities here in the United States,” he said.

Published in Dawn, May 4th, 2020

Opinion

Editorial

Kurram atrocity
Updated 22 Nov, 2024

Kurram atrocity

It would be a monumental mistake for the state to continue ignoring the violence in Kurram.
Persistent grip
22 Nov, 2024

Persistent grip

An audit of polio funds at federal and provincial levels is sorely needed, with obstacles hindering eradication efforts targeted.
Green transport
22 Nov, 2024

Green transport

THE government has taken a commendable step by announcing a New Energy Vehicle policy aiming to ensure that by 2030,...
Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...